Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma/Emergency Medicine | Immunology/Infectious Diseases
Disease Category: COPD (Chronic Obstructive Pulmonary Disease)

Trial Information

Research Trial For Current or Former Smokers

A Phase 3 trial to evaluate the long term safety and effectiveness of 48 weeks of 2 doses versus placebo of an inhaled once daily investigational medication delivered by a novel device in patients with Chronic Obstructive Pulmonary Disease (COPD).

This is a year long trial that will require 12 office visits. Office visits may include physical examinations, EKGs, holter monitoring, vital signs, laboratory testing, spirometry and questionnaires. All sponsor required procedures will be provided at no cost.

Inclusion Criteria:

• Males and females 40 years of age and older
• Current and former smokers

Exclusion Criteria:

• History of Asthma
• Myocardial Infarction within 1 year of visit 1, Hospitalization for heart failure within the past year, Unstable or life threatening cardiac arrhythmia
• Malignancy within the last 5 years other than basal cell carcinoma
• History of significant drug or alcohol abuse
• Daytime oxygen use for more than 1 hour
• Pregnant or nursing women

Emerald Coast Research Associates
221 East 23rd Street Suite B
Panama City, FL 32405
Phone: 850-785-6550
Fax: 850-785-6804

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.